Free Trial

Atossa Genetics (ATOS) Short Interest Ratio & Short Volume

Atossa Genetics logo
$4.85 -0.30 (-5.83%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$4.90 +0.05 (+0.95%)
As of 05/15/2026 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Atossa Genetics Short Interest Overview

As of April 30, 2026, Atossa Genetics (ATOS) had a short interest of 337,509 shares sold short, representing 4.35% of the public float. This marks a -4.10% decrease in short interest since the prior report. The short interest ratio (days to cover) is 6.8, meaning it would take 6.8 days of the average trading volume of 57,454 shares to cover all short positions.

Current Short Interest
337,509 shares
Previous Short Interest
351,934 shares
Change Vs. Previous Month
-4.10%
Dollar Volume Sold Short
$1.81 million
Short Interest Ratio
6.8 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
8,610,000 shares
Short Percent of Float
4.35%
Today's Trading Volume
46,175 shares
Average Trading Volume
57,454 shares
Today's Volume Vs. Average
80%
Short Selling Atossa Genetics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Atossa Genetics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ATOS Short Interest Over Time

ATOS Days to Cover Over Time

ATOS Percentage of Float Shorted Over Time

Atossa Genetics Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026337,509 shares $1.81 million -4.1%4.3%6.8 $5.37
4/15/2026351,934 shares $2.02 million +7.4%4.5%5.64 $5.74
3/31/2026327,683 shares $1.72 million +2.3%4.2%4.52 $5.26
3/13/2026320,202 shares $1.60 million -11.3%4.1%3.25 $5.01
2/27/2026361,039 shares $1.60 million -11.7%4.6%4.86 $4.43
2/13/2026408,724 shares $1.72 million -91.3%5.2%1.31 $4.20
1/30/20264,696,759 shares $39.81 million +29.7%60.2%1.57 $8.48
1/15/20263,621,023 shares $2.10 million +56.4%3.1%3.05 $0.58
12/31/20252,314,959 shares $1.37 million +1.4%2.0%1.87 $0.59
12/15/20252,284,050 shares $1.63 million +47.0%1.9%1.56 $0.71
11/28/20251,554,063 shares $1.22 million +12.7%1.3%3.07 $0.79
11/14/20251,379,122 shares $1.10 million +4.4%1.2%2.61 $0.80
10/31/20251,320,496 shares $1.17 million -3.6%1.1%1.82 $0.89
10/15/20251,370,000 shares $1.44 million -41.7%1.2%1.3 $1.05
9/30/20252,350,000 shares $2.04 million -16.1%N/A2.4 $0.87
9/15/20252,800,000 shares $2.29 million -21.6%N/A2.6 $0.82
8/31/20253,570,000 shares $2.72 million -2.5%3.0%3.3 $0.76
8/15/20253,660,000 shares $2.84 million -3.9%N/A3.3 $0.78
7/31/20253,810,000 shares $3.18 million -6.9%3.2%3.3 $0.83
7/15/20254,090,000 shares $3.74 million -12.4%N/A4.3 $0.91
6/30/20254,670,000 shares $3.88 million -37.1%3.9%4.9 $0.83
6/15/20257,420,000 shares $6.16 million -2.6%6.2%10.5 $0.83
5/31/20257,620,000 shares $5.98 million +6.7%6.6%11.1 $0.78
5/15/20257,140,000 shares $7.04 million +0.1%6.1%11 $0.99
4/30/20257,130,000 shares $6.40 million -6.6%N/A11.6 $0.90
4/15/20257,630,000 shares $4.76 million -5.8%6.6%12 $0.62
3/31/20258,100,000 shares $5.45 million -5.6%7.0%12 $0.67
3/15/20258,580,000 shares $6.18 million -3.2%7.4%12.3 $0.72
2/28/20258,860,000 shares $6.78 million -1.5%7.6%11.5 $0.77
2/15/20258,990,000 shares $7.46 million -2.8%7.7%10.9 $0.83
1/31/20259,250,000 shares $7.79 million +5.8%N/A10.6 $0.84
1/15/20258,740,000 shares $7.60 million +2.0%N/A10.6 $0.87
12/31/20248,570,000 shares $8.09 million +4.5%N/A11.3 $0.94
12/15/20248,200,000 shares $9.18 million -29.3%N/A11.6 $1.12
11/30/202411,600,000 shares $15.08 million -6.8%N/A18.5 $1.30
11/15/202412,450,000 shares $15.94 million -2.5%N/A20.5 $1.28
10/31/202412,770,000 shares $17.62 million -2.2%N/A24.4 $1.38
10/15/202413,050,000 shares $18.66 million +0.9%N/A24.1 $1.43
9/30/202412,930,000 shares $19.65 million -1.9%N/A20 $1.52
9/15/202413,180,000 shares $20.03 million +2.2%N/A13.2 $1.52
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)

When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.tc pixel

See the stock Musk's own words pointed to right here
8/31/202412,900,000 shares $17.67 million +0.3%N/A12.8 $1.37
8/15/202412,860,000 shares $16.46 million +1.1%N/A12 $1.28
7/31/202412,720,000 shares $17.17 million +3.1%N/A10.4 $1.35
7/15/202412,340,000 shares $17.28 million +20.0%N/A9.3 $1.40
6/30/202410,280,000 shares $12.23 million -5.6%N/A6.8 $1.19
6/15/202410,890,000 shares $13.07 million -2.9%N/A6.4 $1.20
5/31/202411,220,000 shares $14.59 million -2.3%N/A5.9 $1.30
5/15/202411,480,000 shares $18.48 million +0.4%N/A6 $1.61
4/30/202411,440,000 shares $17.27 million -7.4%N/A6.4 $1.51
4/15/202412,350,000 shares $21.12 million +17.0%N/A7.6 $1.71
3/31/202410,560,000 shares $19.01 million +24.5%N/A7.7 $1.80
3/15/20248,480,000 shares $10.94 million +18.6%N/A9 $1.29
2/29/20247,150,000 shares $6.99 million +1.6%N/A13.6 $0.98
2/15/20247,040,000 shares $7.11 million +2.9%N/A16.8 $1.01
1/31/20246,840,000 shares $5.84 million -2.2%N/A17.4 $0.85
1/15/20246,990,000 shares $6.36 million +9.9%N/A18.4 $0.91
12/31/20236,360,000 shares $5.60 million +1.0%N/A16.7 $0.88
12/15/20236,300,000 shares $4.67 million +1.0%N/A19.3 $0.74
11/30/20236,240,000 shares $4.64 million -2.0%N/A19.3 $0.74
11/15/20236,370,000 shares $4.17 million -4.2%N/A17.4 $0.65
10/31/20236,650,000 shares $4.46 million -5.7%N/A16.4 $0.67
10/15/20237,050,000 shares $4.65 million -2.8%N/A16.3 $0.66
9/30/20237,250,000 shares $5.34 million -8.8%N/A13.1 $0.74
9/15/20237,950,000 shares $6.28 million -3.1%N/A9.7 $0.79
8/31/20238,200,000 shares $6.48 million -1.8%N/A9.6 $0.79
8/15/20238,350,000 shares $7.36 million -1.7%N/A8.6 $0.88
7/31/20238,490,000 shares $9.34 million -2.6%N/A9.1 $1.10
7/15/20238,720,000 shares $10.81 million +12.5%N/A9.5 $1.24
6/30/20237,750,000 shares $9.77 million +6.9%N/A9.8 $1.26
6/15/20237,250,000 shares $6.52 million -3.6%N/A14.4 $0.90
5/31/20237,520,000 shares $6.99 million -3.2%N/A16.1 $0.93
5/15/20237,770,000 shares $5.50 million -3.7%N/A22.4 $0.71
4/30/20238,070,000 shares $5.16 million -3.1%N/A24.9 $0.64
4/15/20238,330,000 shares $6.12 million -1.3%N/A24.4 $0.74
3/31/20238,440,000 shares $6.12 million -1.9%N/A19.4 $0.72
3/15/20238,600,000 shares $5.59 million +0.6%N/A17.1 $0.65
2/28/20238,550,000 shares $6.33 million -2.2%N/A15.5 $0.74
2/15/20238,740,000 shares $6.69 million -0.6%N/A15.9 $0.77
1/31/20238,790,000 shares $7.04 million -3.2%N/A15.6 $0.80
1/15/20239,080,000 shares $7.75 million -1.7%N/A15.5 $0.85
12/30/20229,240,000 shares $4.88 million -3.7%N/A18.1 $0.53
12/15/20229,590,000 shares $5.61 million -4.3%N/A21.2 $0.59
11/30/202210,020,000 shares $7.52 million -4.1%N/A22.4 $0.75
11/15/202210,450,000 shares $8.58 million -0.2%N/A23.7 $0.82
10/31/202210,470,000 shares $10.32 million -1.2%N/A19.5 $0.99
10/15/202210,600,000 shares $8.59 million -5.8%N/A19.2 $0.81
9/30/202211,250,000 shares $9.37 million -1.6%N/A18.9 $0.83
9/15/202211,430,000 shares $10.53 million -2.8%N/A11.8 $0.92
8/31/202211,760,000 shares $10.83 million -1.3%N/A10.1 $0.92
8/15/202211,910,000 shares $13.58 million -3.7%N/A9 $1.14
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)

When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.tc pixel

See the stock Musk's own words pointed to right here
7/31/202212,370,000 shares $11.64 million -1.9%N/A8.9 $0.94
7/15/202212,610,000 shares $12.99 million -3.7%N/A7.9 $1.03
6/30/202213,100,000 shares $14.28 million -18.3%N/A7.5 $1.09
6/15/202216,040,000 shares $16.68 million -1.3%N/A8.7 $1.04
5/31/202216,250,000 shares $15.80 million -5.2%N/A9.4 $0.97
5/15/202217,140,000 shares $16.90 million -11.4%N/A9.4 $0.99
4/30/202219,350,000 shares $19.54 million +8.9%N/A9.6 $1.01
4/15/202217,770,000 shares $19.72 million +1.7%N/A8.7 $1.11
3/31/202217,480,000 shares $21.85 million -2.7%N/A8.4 $1.25
3/15/202217,960,000 shares $21.19 million +7.4%N/A7.5 $1.18
2/28/202216,720,000 shares $20.40 million -1.1%N/A6.6 $1.22
2/15/202216,910,000 shares $23.34 million +2.3%N/A6.4 $1.38
1/31/202216,530,000 shares $22.65 million -3.7%14.1%5.7 $1.37
1/15/202217,160,000 shares $25.05 million -0.8%N/A5.7 $1.46
12/31/202117,290,000 shares $27.66 million -3.8%N/A5.3 $1.60
12/15/202117,980,000 shares $35.42 million No ChangeN/A5.3 $1.97
11/30/202117,980,000 shares $40.81 million -3.1%N/A4.6 $2.27
11/15/202118,550,000 shares $47.67 million -3.3%N/A4 $2.57
10/29/202119,190,000 shares $49.32 million -8.5%N/A3.9 $2.57
10/15/202120,970,000 shares $59.97 million -5.9%N/A3.3 $2.86
9/30/202122,280,000 shares $72.63 million -5.9%N/A2.4 $3.26
9/15/202123,670,000 shares $78.82 million -3.8%N/A1.7 $3.33
8/31/202124,600,000 shares $93.48 million +3.9%N/A1.5 $3.80
8/13/202123,670,000 shares $76.22 million -24.3%N/A1.2 $3.22
7/30/202131,280,000 shares $93.53 million +21.6%N/A1.5 $2.99
7/15/202125,730,000 shares $144.60 million +25.3%21.3%1.2 $5.62
6/30/202120,530,000 shares $129.75 million +24.3%17.0%1.1 $6.32
6/15/202116,520,000 shares $76.32 million +20.0%13.7%1.1 $4.62
5/28/202113,770,000 shares $44.34 million +2.9%11.4%1 $3.22

ATOS Short Interest - Frequently Asked Questions

Short interest is the volume of Atossa Genetics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 337,509 shares of ATOS short. 4.35% of Atossa Genetics' shares are currently sold short. Learn More on Atossa Genetics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATOS shares currently have a short interest ratio of 6.8. Learn More on Atossa Genetics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.35% of Atossa Genetics' floating shares are currently sold short.

Atossa Genetics saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 337,509 shares, a decline of 4.1% from the previous total of 351,934 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

4.35% of Atossa Genetics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Atossa Genetics: Enlivex Therapeutics Ltd. (0.26%), InflaRx N.V. (3.29%), Lifecore Biomedical, Inc. (10.69%), Adagene Inc. Sponsored ADR (1.79%), Korro Bio, Inc. (8.12%), Pyxis Oncology, Inc. (3.53%), Black Diamond Therapeutics, Inc. (8.61%), Hillstream Biopharma Inc. (6.29%), Tonix Pharmaceuticals Holding Corp. (19.85%), ProQR Therapeutics N.V. (0.88%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling ATOS is an investing strategy that aims to generate trading profit from Atossa Genetics as its price is falling. ATOS shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Atossa Genetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATOS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATOS, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ATOS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:ATOS) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners